These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28173853)
21. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial. Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064 [TBL] [Abstract][Full Text] [Related]
22. [Evaluation of the efficacy and safety of three 2-drug combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Senegal: artesunate-amodiaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine]. Sow D; Ndiaye JL; Sylla K; Ba MS; Tine RC; Faye B; Pene M; Ndiaye M; Seck A; Lo AC; Abiola A; Dieng Y; Gaye O Med Sante Trop; 2016; 26(1):45-50. PubMed ID: 26644184 [TBL] [Abstract][Full Text] [Related]
23. In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique. Nhama A; Bassat Q; Enosse S; Nhacolo A; Mutemba R; Carvalho E; Naueia E; Sevene E; Guinovart C; Warsame M; Sanz S; Mussa A; Matsinhe G; Alonso P; Tiago A; Macete E Malar J; 2014 Aug; 13():309. PubMed ID: 25108397 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of the comparative efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine and artesunate-amodiaquine-chlorpheniramine (Artemoclo™) for the treatment of acute uncomplicated malaria in Nigerian children. Falade CO; Dada-Adegbola HO; Ogunkunle OO; Oguike MC; Nash O; Ademowo OG Med Princ Pract; 2014; 23(3):204-11. PubMed ID: 24732940 [TBL] [Abstract][Full Text] [Related]
25. Effects of amodiaquine, artesunate, and artesunate-amodiaquine on Plasmodium falciparum malaria-associated anaemia in children. Sowunmi A; Balogun ST; Gbotosho GO; Happi CT Acta Trop; 2009 Jan; 109(1):55-60. PubMed ID: 18992209 [TBL] [Abstract][Full Text] [Related]
26. Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia. Otienoburu SD; Maïga-Ascofaré O; Schramm B; Jullien V; Jones JJ; Zolia YM; Houzé P; Ashley EA; Kiechel JR; Guérin PJ; Le Bras J; Houzé S Malar J; 2016 Sep; 15(1):452. PubMed ID: 27596849 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial. Schramm B; Valeh P; Baudin E; Mazinda CS; Smith R; Pinoges L; Dhorda M; Boum Y; Sundaygar T; Zolia YM; Jones JJ; Comte E; Houzé P; Jullien V; Carn G; Kiechel JR; Ashley EA; Guérin PJ Malar J; 2013 Jul; 12():251. PubMed ID: 23866774 [TBL] [Abstract][Full Text] [Related]
28. Randomized comparison of the efficacies and tolerabilities of three artemisinin-based combination treatments for children with acute Plasmodium falciparum malaria in the Democratic Republic of the Congo. Onyamboko MA; Fanello CI; Wongsaen K; Tarning J; Cheah PY; Tshefu KA; Dondorp AM; Nosten F; White NJ; Day NP Antimicrob Agents Chemother; 2014 Sep; 58(9):5528-36. PubMed ID: 25001306 [TBL] [Abstract][Full Text] [Related]
29. Therapeutic efficacy and effect on gametocyte carriage of an artemisinin and a non-based combination treatment in children with uncomplicated P. falciparum malaria, living in an area with high-level chloroquine resistance. Okafor HU; Shu EN; Oguonu T J Trop Pediatr; 2010 Dec; 56(6):398-406. PubMed ID: 20144932 [TBL] [Abstract][Full Text] [Related]
31. Therapeutic efficacy and effects of artemether-lumefantrine and amodiaquine-sulfalene-pyrimethamine on gametocyte carriage in children with uncomplicated Plasmodium falciparum malaria in southwestern Nigeria. Sowunmi A; Gbotosho GO; Happi CT; Adedeji AA; Fehintola FA; Folarin OA; Tambo E; Fateye BA Am J Trop Med Hyg; 2007 Aug; 77(2):235-41. PubMed ID: 17690392 [TBL] [Abstract][Full Text] [Related]
32. High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Falade CO; Ogundele AO; Yusuf BO; Ademowo OG; Ladipo SM Trop Med Int Health; 2008 May; 13(5):635-43. PubMed ID: 18346028 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of fixed-dose artesunate-amodiaquine vs. artemether-lumefantrine for repeated treatment of uncomplicated malaria in Ugandan children. Yeka A; Lameyre V; Afizi K; Fredrick M; Lukwago R; Kamya MR; Talisuna AO PLoS One; 2014; 9(12):e113311. PubMed ID: 25436614 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of artemether-lumefantrine, artesunate-amodiaquine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Davlantes E; Dimbu PR; Ferreira CM; Florinda Joao M; Pode D; Félix J; Sanhangala E; Andrade BN; Dos Santos Souza S; Talundzic E; Udhayakumar V; Owens C; Mbounga E; Wiesner L; Halsey ES; Martins JF; Fortes F; Plucinski MM Malar J; 2018 Apr; 17(1):144. PubMed ID: 29615039 [TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial. Djallé D; Njuimo SP; Manirakiza A; Laganier R; Le Faou A; Rogier C Malar J; 2014 Jan; 13():9. PubMed ID: 24393479 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of Artemisinin-Based Combination Treatments of Uncomplicated Falciparum Malaria in Under-Five-Year-Old Nigerian Children Ten Years Following Adoption as First-Line Antimalarials. Ebenebe JC; Ntadom G; Ambe J; Wammanda R; Jiya N; Finomo F; Emechebe G; Mokuolu O; Akano K; Agomo C; Folarin OA; Oguche S; Useh F; Oyibo W; Aderoyeje T; Abdulkadir M; Ezeigwe NM; Happi C; Sowunmi A; Am J Trop Med Hyg; 2018 Sep; 99(3):649-664. PubMed ID: 29943725 [TBL] [Abstract][Full Text] [Related]
37. An open randomized controlled trial to compare the efficacy of two fixed dose combinations of artemesinin based combinations for uncomplicated falciparum malaria in Bangladesh. Samad R; Rahman MR; Yunus EB; Hussain MA; Arif SM; Islam MN; Hafiz SA; Hossain MM; Faiz MA Bangladesh Med Res Counc Bull; 2013 Dec; 39(3):109-15. PubMed ID: 26118157 [TBL] [Abstract][Full Text] [Related]
38. Therapeutic efficacy of artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria from three highly malarious states in India. Bharti PK; Shukla MM; Ringwald P; Krishna S; Singh PP; Yadav A; Mishra S; Gahlot U; Malaiya JP; Kumar A; Prasad S; Baghel P; Singh M; Vadadi J; Singh MP; Bustos MD; Ortega LI; Christophel EM; Kashyotia SS; Sonal GS; Singh N Malar J; 2016 Oct; 15(1):498. PubMed ID: 27737665 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial. Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]